-
{{ listItem.name }}快速筛选药品，用摩熵药筛
微信扫一扫-立即使用
-
产品立项评估及管线规划
-
数据定制服务
-
产业/行业调研
-
市场洞察咨询服务
-
报告大厅
已收录 68518 份 -
摩熵说直播
最新改良型新药及创新药立项开发
- GLP-1
【ChiCTR2100044023】The Impact of Thyroid Tumor Features on Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients in Head and Neck Department at KAMC: A Retrospective Cross-Sectional Study
ChiCTR2100044023
结束
/
/
/
2021-03-06
/
/
Papillary Thyroid Carcinoma
The Impact of Thyroid Tumor Features on Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients in Head and Neck Department at KAMC: A Retrospective Cross-Sectional Study
The Impact of Thyroid Tumor Features on Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients
Primary: To evaluate the association between the size of the tumor and number of lymph node metastasis in papillary thyroid carcinoma patients
连续入组
探索性研究/预试验
No
N/A
No
/
125
/
2020-07-09
2021-01-07
/
All patients with pathologically confirmed papillary thyroid carcinoma with lymph node metastasis；
登录查看1. Patients with papillary thyroid carcinoma without neck dissection; 2. Patients with papillary thyroid carcinoma thyroidectomy was done outside KAMC.；
登录查看No
/
No的其他临床试验
- Dr. Emma Barlow, please contact us to upload the official ethical approval document. Beyond COVID-19: Defining a role for Webinars in Surgical Training - a Trainee Consensus
- The effects of the COVID19 pandemic on the acute surgery care on our Surgery Unit
- Consultant Aspirations: A Surgical Trainee Consensus Process – A Qualitative Study
- The Impact of Thyroid Tumor Features on Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients in Head and Neck Department at KAMC: A Retrospective Cross-Sectional Study
- The incidence of Gall Stones after Bariatric surgery and its association with weight loss
- Which score to predict diabetes remission?
- Effect of Pilates group exercises on transversus abdominis, function and pain in females with chronic low back pain
- short term outcomes for one stage and two stage basilic vein trans positioning (BVT) in patients with small cephalic vein caliber
- Evaluation of Biomarkers for Prediction of Morbidity and Mortality in COVID-19 at a Tertiary Care Center in Pakistan
- delayed presentation of acute limb ischemia: a sinister
- Transpositioning of basilic vein for vascular acess for the hemodialysis: An experience of a tertiary care hospital
- 该研究尚未获得伦理委员会批准。请于批准后才开始纳入参试者，并与我们联系上传批件。The effectiveness of Crew Resource Management based Simulation Training (CRM-ST) program in improving student midwives' performance
- Association of Body Mass Index and diet with Symptomatic Gall Stone Disease: A Case-Control Study
- Comparison of the safety and efficacy of single-stage ERCP plus Laparoscopic cholecystectomy versus two-stage ERCP followed by Laparoscopic cholecystectomy 6 to 8 weeks later
- Insulin resistance and vitamin D deficiency are frequently seen in diabetic patients. Vitamin D deficiency can have a negative effect on blood glucose level and weight loss.
- Unusual position of appendix in specific group of pediatric patients
- The effectiveness of dancing program on relieving the symptom cluster of fatigue-sleep disturbance-depression among breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial
- Evaluation of BCL2 and TNFα as mRNA Biomarkers for Monitoring The Immune Response in Critically ill Children
- The effect of dietary fibers and red rice extract on cholesterol level and body weight
- A comparison of the efficacy of fibrin glue versus suction drainage in preventing hematoma and seroma in rhytidectomy: a randomized, double-blind, controlled trial
沙特阿拉伯Head and Neck and Skull Base Health Center, King Abdullah Medical City的其他临床试验
最新临床资讯
-
重磅！全球首个偏向型GLP-1减重药中国III期临床数据荣登《柳叶刀》子刊
-
新药每周一次，93%中国患者成功减重，还降三高、尿酸和脂肪肝！纪立农教授领衔研究登《柳叶刀》子刊
-
diabetes 埃诺格鲁肽 SLIMMER
医药笔记2025-06-22
-
遗传性血管性水肿 III期 BD项目
美柏资本2025-06-22
-
ADA GIPR PCSK9
信达生物2025-06-22
-
diabetes 埃诺格鲁肽 内分泌学
先为达生物2025-06-22
-
PDL1 三阴性乳腺癌 atezolizumab
BioArtMED2025-06-21
-
EGFR 结直肠癌 JMT101
石药集团2025-06-21
-
糖尿病 GLP-1/GIP
恒瑞医药2025-06-21
-
肥胖 Wegovy
一度医药2025-06-21
18983288589（微信同号）
18983288589（微信同号）
18908392210（微信同号）
18980413049
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: tyc7111cc太阳成集团 tyc7111cc太阳成集团企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网